Jordan Ohlsson, MD, Fellow-In-Training

News

New developments on the forefront of intermediate-risk pulmonary embolism

Author:

Jordan Ohlsson, MD, Fellow-In-Training

While systemic anticoagulation is the mainstay therapy, select individuals may benefit from more immediate reperfusion.

• Read More